AI Article Synopsis
- The study aimed to assess how effective and safe topical 1% medroxyprogesterone is for healing the corneal epithelium after photorefractive keratectomy (PRK).
- It involved 66 eyes from 33 patients, where one eye received the medication and the other got a placebo, with follow-ups for 5 days post-surgery to measure healing time.
- Results showed no significant differences in healing between the two groups, indicating that 1% medroxyprogesterone does not meaningfully enhance corneal epithelial healing after PRK.
Article Abstract
Objective: The objective of the study was to evaluate the efficacy and safety of topical 1% medroxyprogesterone in corneal epithelial healing after photorefractive keratectomy (PRK).
Methods: In this placebo-controlled double-masked randomized contralateral eye study, 66 eyes of 33 patients with myopia and myopia-astigmatism were assigned into two groups to receive either 1% topical medroxyprogesterone (intervention) or artificial tear (placebo) at the end of PRK surgery. The patients were followed up daily for 5 days until epithelial healing was achieved. The time taken for epithelial healing was the main outcome measure.
Findings: The mean age of the subjects was 32.97 ± 7.6 years and 46 individuals were female (69.7%). All baseline refractive characteristics were comparable between the groups. There was no significant difference between the two groups in terms of epithelial defect size on Day 1 (: 0.67). Both groups exhibited a consistent pattern of decreasing epithelial defect size from Day 1 to Day 5, with the control group having slightly worse initial values. There were no significant differences between the groups in the following days. Both groups showed substantial reductions in the epithelial defect size, but the intervention group showed a more prominent decrease on Day 2. The intervention did not show a significant statistical difference compared to the control group, and both groups ended up with a similar outcome.
Conclusion: These findings suggest that the topical 1% medroxyprogesterone does not significantly affect the healing of corneal epithelium after PRK.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11524572 | PMC |
| http://dx.doi.org/10.4103/jrpp.jrpp_26_24 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Topical Medroxyprogesterone Acetate and Corneal Epithelium Healing after Photorefractive Keratectomy: A Randomized, Double-masked Contralateral Eye Study.
J Res Pharm Pract
September 2024
Department of Ophthalmology, Isfahan Eye Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Article Synopsis
- The study aimed to assess how effective and safe topical 1% medroxyprogesterone is for healing the corneal epithelium after photorefractive keratectomy (PRK).
- It involved 66 eyes from 33 patients, where one eye received the medication and the other got a placebo, with follow-ups for 5 days post-surgery to measure healing time.
- Results showed no significant differences in healing between the two groups, indicating that 1% medroxyprogesterone does not meaningfully enhance corneal epithelial healing after PRK.
Neurotrophic Keratopathy in Marfan Syndrome Patient After Micropulse Transscleral Cyclophotocoagulation: A Call for Risk Stratification.
Am J Case Rep
February 2024
Department of Glaucoma, King Khalid Eye Specialist Hospital, Riyadh, Saudi Arabia.
BACKGROUND Micropulse transscleral cyclophotocoagulation is a non-invasive, widely employed procedure that uses diode laser to target the ciliary body to lower the intraocular pressure. Despite its acknowledged efficacy, certain complications are recognized, with neurotrophic keratopathy being a rare yet serious consequence. This report seeks to shed light on a potential high-risk subgroup susceptible to neurotrophic keratopathy, exemplified by our patient with Marfan syndrome, a condition characterized by thin sclera.
View Article and Find Full Text PDFThe Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review.
Front Cell Infect Microbiol
January 2022
Central Clinical School, Monash University, Carlton, VIC, Australia.
Background: Exogenous sex steroids within hormonal contraception and menopausal hormone therapy (MHT) have been used for family planning and management of menopausal symptoms, without consideration of their effects on the vaginal microbiota. This is largely because their use predates our understanding of the importance of the vaginal microbiome on human health. We conducted a systematic review (PROSPERO: CRD42018107730) to determine the influence of exogenous sex steroids, stratified by oestrogen-containing or progestin-only types of contraception, and MHT on the vaginal microbiome, as measured by molecular methods.
View Article and Find Full Text PDFHigh-Resolution Quantitative Mapping of Macaque Cervicovaginal Epithelial Thickness: Implications for Mucosal Vaccine Delivery.
Front Immunol
October 2021
Southwest National Primate Research Center, San Antonio, TX, United States.
Vaginal mucosal surfaces naturally offer some protection against sexually transmitted infections (STIs) including Human Immunodeficiency Virus-1, however topical preventative medications or vaccine designed to boost local immune responses can further enhance this protection. We previously developed a novel mucosal vaccine strategy using viral vectors integrated into mouse dermal epithelium to induce virus-specific humoral and cellular immune responses at the site of exposure. Since vaccine integration occurs at the site of cell replication (basal layer 100-400 micrometers below the surface), temporal epithelial thinning during vaccine application, confirmed with high resolution imaging, is desirable.
View Article and Find Full Text PDFTNF-α Inhibitors for the Management of Intractable Corneal Melt: Report of Three Cases and Review of the Literature.
Eye Contact Lens
June 2021
Department of Ophthalmology (C.A.U., D.Ö., B.A., I.D.), Dokuz Eylul University, Izmir, Turkey ; Izmir Biomedicine and Genome Center (C.A.U.), Izmir, Turkey ; and Department of Rheumatology (M.B., A.K.), Dokuz Eylul University, Izmir, Turkey.
Objective: To report three consecutive cases with noninfectious corneal melting, whose disease progression could only be halted with tumor necrosis-α (TNF-α) inhibitor infusion, with a review of the relevant literature.
Materials And Methods: Patients with toxic epidermal necrolysis, severe alkaline burn, and Sjögren syndrome had experienced severe corneal melting following penetrating keratoplasty, Boston type 1 keratoprosthesis implantation or spontaneously, respectively. Topical autologous serum eye-drops, medroxyprogesterone, and acetylcysteine formulations; frequent nonpreserved lubrication; systemic tetracyclines and vitamin-C supplements; topical and systemic steroids and steroid-sparing agents; surgical approaches including amniotic membrane transplantation, tectonic graft surgery; and tarsorraphy failed to alter the disease courses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!